Pharmacological differences between muscarinic receptors coupled to phosphoinositide turnover and those coupled to adenylate cyclase inhibition
- 1 May 1989
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 38 (10) , 1605-1616
- https://doi.org/10.1016/0006-2952(89)90308-0
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Muscarinic receptor-mediated increase in cAMP levels in SK-N-SH human neuroblastoma cellsBiochemical and Biophysical Research Communications, 1988
- Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypesNature, 1988
- Molecular Properties of the Muscarinic Acetylcholine ReceptorAnnual Review of Neuroscience, 1987
- Phosphatidylinositol turnover in neuroblastoma cells: Regulation by bradykinin, acetylcholine, but not μ- and δ-opioid receptorsNeuroscience Letters, 1986
- The Coupling of the Neuronal Muscarinic Receptor to ResponsesAnnual Review of Pharmacology and Toxicology, 1984
- Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositolBiochemical Journal, 1983
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980
- Pirenzepine distinguishes between different subclasses of muscarinic receptorsNature, 1980
- Muscarinic response to acetylcholine in neuroblastoma × glioma hybrid cellsNature, 1975
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973